Novo Nordisk (NVO) has a notable new trial that starts this week, says Michael Nedelcovych. He discusses how Cowen has a buy rating on NVO. He also talks about NVO's earnings which were released November 2nd. He then goes over how to look for winners in the pharma space, highlighting Eli Lilly and Company (LLY). tune in to find out more about the stock market today.
10 Nov 2022
Market On Close
23 May 2023
The Watch List
17 May 2023
Market On Close
28 Mar 2023
Market On Close
03 May 2023
The Watch List
22 May 2023
Next Gen Investing
18 Apr 2023